These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 1322432

  • 1. Expression of type I, but not type II insulin-like growth factor receptor on both undifferentiated and differentiated HT29 human colon carcinoma cell line.
    Remacle-Bonnet MM, Culouscou JM, Garrouste FL, Rabenandrasana C, Marvaldi JL, Pommier GJ.
    J Clin Endocrinol Metab; 1992 Aug; 75(2):609-16. PubMed ID: 1322432
    [Abstract] [Full Text] [Related]

  • 2. Insulin and insulin-like growth factor (somatomedin) receptors on cloned rat pituitary tumor cells.
    Rosenfeld RG, Ceda G, Cutler CW, Dollar LA, Hoffman AR.
    Endocrinology; 1985 Nov; 117(5):2008-16. PubMed ID: 2995005
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Insulin-like growth factor-II expression in carcinoma in colon cell lines: implications for autocrine actions.
    Guo YS, Jin GF, Townsend CM, Zhang T, Sheng HM, Beauchamp RD, Thompson JC.
    J Am Coll Surg; 1995 Aug; 181(2):145-54. PubMed ID: 7627387
    [Abstract] [Full Text] [Related]

  • 5. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ, Garrouste FL, el Atiq F, Roccabianca M, Marvaldi JL, Remacle-Bonnet MM.
    Cancer Res; 1992 Jun 01; 52(11):3182-8. PubMed ID: 1375536
    [Abstract] [Full Text] [Related]

  • 6. Insulin-like growth factor II binding to the type I somatomedin receptor. Evidence for two high affinity binding sites.
    Casella SJ, Han VK, D'Ercole AJ, Svoboda ME, Van Wyk JJ.
    J Biol Chem; 1986 Jul 15; 261(20):9268-73. PubMed ID: 3013881
    [Abstract] [Full Text] [Related]

  • 7. Characterization of type I and type II insulin-like growth factor receptors in an intestinal epithelial cell line.
    Park JH, Vanderhoof JA, Blackwood D, Macdonald RG.
    Endocrinology; 1990 Jun 15; 126(6):2998-3005. PubMed ID: 2161743
    [Abstract] [Full Text] [Related]

  • 8. Autocrine regulation of human tumor cell proliferation by insulin-like growth factor II: an in-vitro model.
    Thompson MA, Cox AJ, Whitehead RH, Jonas HA.
    Endocrinology; 1990 Jun 15; 126(6):3033-42. PubMed ID: 1693565
    [Abstract] [Full Text] [Related]

  • 9. Insulin-like growth factor (IGF) binding to human fibroblast and glioblastoma cells: the modulating effect of cell released IGF binding proteins (IGFBPs).
    McCusker RH, Camacho-Hubner C, Bayne ML, Cascieri MA, Clemmons DR.
    J Cell Physiol; 1990 Aug 15; 144(2):244-53. PubMed ID: 2166057
    [Abstract] [Full Text] [Related]

  • 10. Receptors for insulin-like growth factors-I and -II in osteoblast-enriched cultures from fetal rat bone.
    Centrella M, McCarthy TL, Canalis E.
    Endocrinology; 1990 Jan 15; 126(1):39-44. PubMed ID: 2152868
    [Abstract] [Full Text] [Related]

  • 11. Insulin-like growth factor I receptors in normal and neoplastic human endometrium.
    Talavera F, Reynolds RK, Roberts JA, Menon KM.
    Cancer Res; 1990 May 15; 50(10):3019-24. PubMed ID: 2159368
    [Abstract] [Full Text] [Related]

  • 12. Insulin-like growth factor receptors and binding protein in rat neuroblastoma cells.
    Sturm MA, Conover CA, Pham H, Rosenfeld RG.
    Endocrinology; 1989 Jan 15; 124(1):388-96. PubMed ID: 2462492
    [Abstract] [Full Text] [Related]

  • 13. Type-II insulin-like growth-factor receptor in conditioned medium from HT-29 human colon carcinoma cell line.
    Garrouste F, Remacle-Bonnet M, Culouscou JM, Marvaldi J, Pommier G.
    Int J Cancer; 1991 Mar 12; 47(5):760-4. PubMed ID: 1848538
    [Abstract] [Full Text] [Related]

  • 14. Interaction of insulin-like growth factors with a nonfusing mouse muscle cell line: binding, action, and receptor down-regulation.
    de Vroede MA, Romanus JA, Standaert ML, Pollet RJ, Nissley SP, Rechler MM.
    Endocrinology; 1984 May 12; 114(5):1917-29. PubMed ID: 6325137
    [Abstract] [Full Text] [Related]

  • 15. Receptor-mediated endocytosis and lysosomal processing of insulin-like growth factor I by mitogenically responsive cells.
    Furlanetto RW.
    Endocrinology; 1988 May 12; 122(5):2044-53. PubMed ID: 2966062
    [Abstract] [Full Text] [Related]

  • 16. des-(1-3)-IGF-I, an insulin-like growth factor analog used to mimic a potential IGF-II autocrine loop, promotes the differentiation of human colon-carcinoma cells.
    Remacle-Bonnet M, Garrouste F, el Atiq F, Roccabianca M, Marvaldi J, Pommier G.
    Int J Cancer; 1992 Dec 02; 52(6):910-7. PubMed ID: 1281142
    [Abstract] [Full Text] [Related]

  • 17. High-affinity insulin binding to an atypical insulin-like growth factor-I receptor in human breast cancer cells.
    Milazzo G, Yip CC, Maddux BA, Vigneri R, Goldfine ID.
    J Clin Invest; 1992 Mar 02; 89(3):899-908. PubMed ID: 1311720
    [Abstract] [Full Text] [Related]

  • 18. Insulin-like growth factor receptors in rat placental membranes.
    Pilistine SJ, Moses AC, Munro HN.
    Endocrinology; 1984 Sep 02; 115(3):1060-5. PubMed ID: 6086283
    [Abstract] [Full Text] [Related]

  • 19. Insulin-like growth factor (IGF) binding protein from human decidua inhibits the binding and biological action of IGF-I in cultured choriocarcinoma cells.
    Ritvos O, Ranta T, Jalkanen J, Suikkari AM, Voutilainen R, Bohn H, Rutanen EM.
    Endocrinology; 1988 May 02; 122(5):2150-7. PubMed ID: 2452077
    [Abstract] [Full Text] [Related]

  • 20. Mitogenic effects of human recombinant insulin on B-cell precursor acute lymphoblastic leukemia cells.
    Neely EK, Rosenfeld RG, Illescas A, Smith SD.
    Leukemia; 1992 Nov 02; 6(11):1134-42. PubMed ID: 1434795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.